# | Title | Journal | Year | Citations |
---|
1 | Radiological Assessment of Osteo-Arthrosis | Annals of the Rheumatic Diseases | 1957 | 9,474 |
2 | Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group | Annals of the Rheumatic Diseases | 2002 | 4,586 |
3 | EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update | Annals of the Rheumatic Diseases | 2017 | 3,366 |
4 | 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative | Annals of the Rheumatic Diseases | 2010 | 2,994 |
5 | The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection | Annals of the Rheumatic Diseases | 2009 | 2,713 |
6 | The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 study | Annals of the Rheumatic Diseases | 2014 | 2,433 |
7 | The global burden of low back pain: estimates from the Global Burden of Disease 2010 study | Annals of the Rheumatic Diseases | 2014 | 2,091 |
8 | EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update | Annals of the Rheumatic Diseases | 2020 | 1,860 |
9 | Treating rheumatoid arthritis to target: recommendations of an international task force | Annals of the Rheumatic Diseases | 2010 | 1,711 |
10 | 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative | Annals of the Rheumatic Diseases | 2013 | 1,705 |
11 | EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update | Annals of the Rheumatic Diseases | 2014 | 1,688 |
12 | EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT) | Annals of the Rheumatic Diseases | 2003 | 1,661 |
13 | Studies with pain rating scales. | Annals of the Rheumatic Diseases | 1978 | 1,488 |
14 | EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs | Annals of the Rheumatic Diseases | 2010 | 1,429 |
15 | Articular mobility in an African population. | Annals of the Rheumatic Diseases | 1973 | 1,324 |
16 | The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general | Annals of the Rheumatic Diseases | 2011 | 1,302 |
17 | 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus | Annals of the Rheumatic Diseases | 2019 | 1,265 |
18 | Changes in causes of death in systemic sclerosis, 1972-2002 | Annals of the Rheumatic Diseases | 2007 | 1,246 |
19 | 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis | Annals of the Rheumatic Diseases | 2017 | 1,220 |
20 | EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis | Annals of the Rheumatic Diseases | 2010 | 1,157 |
21 | Dynamic load at baseline can predict radiographic disease progression in medial compartment knee osteoarthritis | Annals of the Rheumatic Diseases | 2002 | 1,135 |
22 | Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force | Annals of the Rheumatic Diseases | 2016 | 1,114 |
23 | 2016 updated EULAR evidence-based recommendations for the management of gout | Annals of the Rheumatic Diseases | 2017 | 1,096 |
24 | The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis | Annals of the Rheumatic Diseases | 2009 | 1,092 |
25 | EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT) | Annals of the Rheumatic Diseases | 2006 | 1,079 |
26 | EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria | Annals of the Rheumatic Diseases | 2010 | 1,073 |
27 | Knee pain and osteoarthritis in older adults: a review of community burden and current use of primary health care | Annals of the Rheumatic Diseases | 2001 | 1,055 |
28 | Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies | Annals of the Rheumatic Diseases | 2006 | 1,041 |
29 | EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis | Annals of the Rheumatic Diseases | 2013 | 1,033 |
30 | Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database | Annals of the Rheumatic Diseases | 2010 | 1,017 |
31 | 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome | Annals of the Rheumatic Diseases | 2017 | 959 |
32 | IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial | Annals of the Rheumatic Diseases | 2008 | 951 |
33 | EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis | Annals of the Rheumatic Diseases | 2016 | 940 |
34 | EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update | Annals of the Rheumatic Diseases | 2017 | 918 |
35 | Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry | Annals of the Rheumatic Diseases | 2020 | 908 |
36 | EULAR recommendations for the management of primary small and medium vessel vasculitis | Annals of the Rheumatic Diseases | 2009 | 889 |
37 | EULAR revised recommendations for the management of fibromyalgia | Annals of the Rheumatic Diseases | 2017 | 880 |
38 | Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis | Annals of the Rheumatic Diseases | 2012 | 868 |
39 | Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. | Annals of the Rheumatic Diseases | 1990 | 867 |
40 | Psoriatic arthritis: epidemiology, clinical features, course, and outcome | Annals of the Rheumatic Diseases | 2005 | 862 |
41 | Estimating the burden of musculoskeletal disorders in the community: the comparative prevalence of symptoms at different anatomical sites, and the relation to social deprivation | Annals of the Rheumatic Diseases | 1998 | 854 |
42 | 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis | Annals of the Rheumatic Diseases | 2011 | 831 |
43 | Modification and validation of the Birmingham Vasculitis Activity Score (version 3) | Annals of the Rheumatic Diseases | 2009 | 825 |
44 | Guidelines for musculoskeletal ultrasound in rheumatology | Annals of the Rheumatic Diseases | 2001 | 822 |
45 | The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study | Annals of the Rheumatic Diseases | 2014 | 820 |
46 | Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review | Annals of the Rheumatic Diseases | 2010 | 817 |
47 | Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement | Annals of the Rheumatic Diseases | 2005 | 815 |
48 | Update of EULAR recommendations for the treatment of systemic sclerosis | Annals of the Rheumatic Diseases | 2017 | 794 |
49 | The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation | Annals of the Rheumatic Diseases | 2016 | 780 |
50 | Synovial tissue inflammation in early and late osteoarthritis | Annals of the Rheumatic Diseases | 2005 | 779 |